BHRT Stock UPDATES Bioheart Inc. (BHRT) 0.0242 09/16/2014 16

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bioheart Inc. (BHRT) 0.0242 $BHRT

Bioheart Announces Grand Opening of Facility in South Africa
Marketwire - Tue Sep 16, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces the grand opening the laboratory and clinic in South Africa.

Bioheart Releases Q2 Financial Information Showing Growth
Marketwire - Thu Aug 07, 7:04AM CDT
Bioheart, Inc. (OTCQB: BHRT) released today financial information based on results from Q2 2014. The financial data shows that Bioheart has grown in product revenues, increased income, reduced debt, and further strengthened the financial standing of the company.

Bioheart Announces World's First Combination Stem Cell Treatment
Marketwire - Thu Jul 24, 7:23AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that it has completed the world's first combination stem cell treatment with Magnum Cell Therapies (Magnum) in Honduras. A patient with congestive heart failure has been treated with a combination of AdipoCell(TM) or adipose derived stem cells and MyoCell(R) or muscle derived stem cells. AdipoCell may help to promote angiogenesis or new blood vessel formation in ischemic tissue while MyoCell may help to promote myogenesis or new muscle formation. The cells were delivered directly into the damaged areas of the heart using the MyoCath(R) Catheter.

Bioheart Announces Grand Opening of Magnum Cell Therapies
Marketwire - Wed Jul 16, 7:02AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that it will participate in the grand opening event of Magnum Cell Therapies (Magnum) in Honduras during the week of July 21st. Bioheart has previously announced the joint venture with Magnum and the goal to bring regenerative therapies to patients in South America.

Bioheart Announces Clinical Trials in India
Marketwire - Mon Jul 07, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that they have begun two clinical trials in India including the first ever combination stem cell trial in the world. The first cardiac patient has successfully been enrolled and treated in India using AdipoCell(TM) or adipose derived stem cells. The second trial will involve the combination of AdipoCell and MyoCell(R) or muscle derived stem cells for congestive heart failure patients. AdipoCell may help to promote angiogenesis or new blood vessel formation in ischemic tissue while MyoCell may help to promote myogenesis or new muscle formation.

Bioheart Announces Joint Venture in South Africa
Marketwire - Tue Jun 24, 7:01AM CDT
Bioheart, Inc. (OTCBB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Dr. Walter Bell of South Africa.

Bioheart to Present at SELECTBIO Clinical Translation of Stem Cells
Marketwire - Wed Apr 02, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will present at the SELECTBIO 2nd Annual Clinical Translation of Stem Cells on April 21st, 2014. The conference brings together basic scientists, clinician-scientists, as well as medical practitioners/surgeons focusing on studying, characterizing, and deploying various classes of stem cells for therapeutic utility.

Bioheart Announces Clinical Study for Degenerative Disc Disease
Marketwire - Wed Mar 26, 1:16PM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will enroll patients in a new study for degenerative disc disease (DDD). The study will enroll up to 100 patients to determine the safety and efficacy of adipose derived stem cells or AdipoCell(TM) in patients with DDD.

Bioheart, Inc. Announces Mike Tomas, President/CEO, Has Been Chosen as an Honoree for Emerge Americas Techweek100 Miami 2014
Marketwire - Tue Mar 25, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that Mike Tomas, President and CEO, has been named as one of the top 100 technology leaders on eMerge Americas Techweek100 Miami 2014. (http://techweek.com/miami/techweek100/).

Bioheart, Inc. to Present at American Association of Orthopedic Medicine on Cell Therapy
Marketwire - Fri Mar 21, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will present at the 31st American Association of Orthopedic Medicine Annual Conference (AAOM) Conference and Scientific Seminar. Co-sponsored by the American Board of Quality Assurance and Utilization Review Physicians, Inc. (ABQAURP), the conference, titled "Sports, Spine and Beyond: Latest Advances in Regenerative Orthopedic Medicine," will focus on the newest breakthroughs in the field of orthopedic medicine.

Galena Biopharma Inc. Share Value Tumbles on News of SEC Investigation
ACCESSWIRE - Wed Mar 19, 10:25AM CDT
Galena Biopharma Inc. (NASDAQ:GALE) share volume soared Mar. 18, with more than 17,653,116 shares changing hands, nearly double its three-month average volume of 9,373,933 shares, while its share value continued to tumble, closing at $2.82, down 40 cents, or 12.42%, from its closing price of $3.22 the previous day. The high volume and stock value tumble are being triggered by the Worcester, Mass-based company's revelation that it is being investigated by the Securities and Exchange Commission. Here is the company's statement: "In February 2014, we learned that the SEC is investigating certain matters relating to our company and an outside investor-relations firm that we retained in 2013. We have been in contact with the SEC staff through our counsel and are cooperating with the investigation," the company stated in its 10-K filing dated Mar. 17. Class-Acton Lawsuits In addition to this bad news, the company is facing a slew of class action lawsuits from stockholders that allege Galena and certain of its executives issued a series of materially false and misleading statements during the Class Period, violating federal securities laws. However, it should be noted that none of these allegations have been proven. Moreover, Galena's results for its fourth quarter were less than comforting to shareholders. Its earnings per share loss of (46c) on revenue of $1.32M as compared to estimates of (9c) and $1.62M, respectively. The company pointed out that the Q4 net loss of $48.5M included $38.9M in non-cash charges. On the positive side, the company lifted its 2014 Abstral net revenue estimates to $11M-$15M as compared to prior guidance of $8M-$12M. Analysts' Consensus Nonetheless, of the 9 analyst firms that cover Galena, 7 rate it a "strong buy," 1 a "buy" and 1 a "sell." Find out what could be the best investor's move when it comes to GALE by getting the complete report here, or by cutting and pasting the following link in your Web browser: http://www.sixfigurestockpicks.com Bioheart Inc.'s Stock Volume Soars on News of Joint Venture with Magnum Cell Therapies Meanwhile, development-stage, biotechnology company Bioheart Inc.'s (OTCQB: BHRT) stock volume continued to soar Mar. 18, with 7,457,880 shares changing hands, nearly three times more than its three-month average volume of 2,607,553 shares.

Bioheart Announces Joint Venture With Magnum Cell Therapies
Marketwire - Mon Mar 17, 7:19AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Magnum Cell Therapies (http://www.magnumterapiacelular.com/).

Generex Biotechnology Corp. Granted Patents on New HPV and Influenza Vaccines
ACCESSWIRE - Wed Mar 12, 11:01AM CDT
Generex Biotechnology Corp. (OTCQB: GNBT) stock volume soared Mar. 11, with 9,325,106 shares changing hands, significantly higher than its three-month average volume of 7,012,285 shares.

Bioheart Boosts Team With Regulatory, Finance and Administrative Expertise
Marketwire - Fri Sep 20, 12:10PM CDT
Bioheart (OTCQB: BHRT), a leader in developing stem cell therapies to treat cardiovascular diseases, has expanded its team by adding three key strategic positions with regulatory, finance and administrative expertise.

Bioheart Inc adds Sheldon T Anderson to board
M2 - Thu Aug 29, 6:05AM CDT
Biotech company Bioheart Inc (OTCQB:BHRT) stated on Wednesday that Sheldon T Anderson has been named to its board of directors.

Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc.
Marketwire - Wed Aug 28, 7:02AM CDT
Sheldon T. Anderson has been elected to the Board of Directors of Bioheart, Inc. (OTCQB: BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage as well as severe peripheral vascular disease. Mr. Anderson is Chairman of the Advisory Board of Northern Trust. He retired last year as Chairman and CEO of the Southeast Region of Northern Trust, where he was responsible for managing the company's investment management, trust and estate planning, private and business banking and financial consulting business in Florida and Georgia.

Bioheart's President / CEO Mike Tomas Appointed to Workforce Florida Board of Directors by Governor Rick Scott
Marketwire - Wed Aug 14, 7:21AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the company's President/CEO, has been appointed to serve on Workforce Florida's Board of Directors for a four year term by Florida Governor Rick Scott. Tomas is one of 15 Floridians appointed to the Board of Directors. Workforce Florida is charged with overseeing the state's workforce system and developing strategies that will improve the state's business environment while supporting its economy (www.EmployFlorida.com).

OTC Daily Alert Stock Watch - Bioheart (OTCBB:BHRT)
WorldStockWire - Tue Aug 13, 12:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Bioheart Inc wins validated FDA registration for stem tissue bank establishment
M2 - Mon Aug 12, 5:56AM CDT
Cardiovascular cell technology company Bioheart Inc (OTCQB:BHRT) said on Friday that it has been awarded a validated registration from the FDA for the initial tissue bank listing.

Bioheart Receives Validated FDA Registration for Tissue Bank Establishment
Marketwire - Fri Aug 09, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that it received a validated registration from the FDA for the initial tissue bank listing. Bioheart is offering stem cell storage for patients enrolled in the studies at the centers of excellence outside the US. This new business unit will create an additional revenue stream for Bioheart. Patients can store stem cell doses in liquid nitrogen for future use in approved clinical trials. These trials focus on the use of LipiCell(TM) (adipose derived stem cells) in a variety of different degenerative diseases.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 37

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 64

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 106

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 63

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 85

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 23

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 160

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 49

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 348

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Flow Beverage Welcomes José Bautista as Advisor and Announces Fundraising Progress

Updated Category News Views 336

Flow Beverage Corp. Welcomes José Bautista as Strategic Advisor Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) has recently made a significant move by bringing on board José Bautista as a Strategic Advisor. This addition is seen as a promising enhancement to the company's team, aligning with its dedication to excellence and innovation in the beverage sector. Background of...

Continue Reading
Milan Laser Hair Removal Marks a Significant 400 Clinic Milestone

Updated Category News Views 207

Milan Laser Hair Removal Reaches 400 Clinics Nationwide The leading provider in laser hair removal achieves a remarkable milestone with nationwide expansion efforts. Milan Laser Hair Removal, the hallmark of laser hair removal in the nation, proudly celebrates the grand opening of its 400th clinic, symbolizing a major advancement in its rapid expansion across the country....

Continue Reading
Global Vertical Roller Mill Market Expands to USD 1.04 Billion

Updated Category News Views 215

Understanding the Global Vertical Roller Mill Market The Vertical Roller Mill (VRM) market is anticipated to experience significant growth in the coming years. Currently valued at approximately USD 608.5 million in 2024, projections indicate that it will reach USD 1,041.2 million by 2033, achieving a compound annual growth rate (CAGR) of 6.1%. This increase is largely due...

Continue Reading
Pulsar Helium Provides Insights on Progress at Topaz Project

Updated Category News Views 313

Pulsar Helium Develops Well-Testing Strategy at Topaz Project Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF), a leading helium development company, has recently provided valuable updates regarding its well-testing activities at the Topaz project, located in Minnesota. This momentous phase in the project holistically aims to assess helium extraction capabilities...

Continue Reading
Trade Disclosures: Treatt plc's Key Operations Analyzed

Updated Category News Views 178

Understanding Recent Trade Disclosures by Treatt plc Treatt plc, a company known for its expertise in manufacturing and distributing essential oils and flavouring agents, operates in a competitive sector where trade disclosures play a crucial role in maintaining transparency and building investor trust. As we delve into the recent disclosures made by Treatt plc, we'll...

Continue Reading